Newsfile Corp
17 Oct 2026, 02:21 UTC · 1h ago
UNICYCIVE DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
Impact · against what's priced in
The news is largely noise for ASTS as the market has already integrated the securities fraud investigation into its valuation. For UNCY and BBNX, the legal deadlines and allegations regarding manufacturing non-compliance present ongoing operational and financial risks.
- ASTS+0.00
Already priced in
- The price assumes
the securities fraud investigation announced in late July





